The patent, titled 'Synergistic Composition For Osteoarthritis,' bears the number 11,147,580. It was awarded by the US Patent Office in late October, the company said.
The patent covers several indications, including inflammation, joint function and collagen breakdown. The patent is broad enough to cover several preparations and dosages.
NXT exec: Fast joint support for health joints is something new
Eric Anderson, managing director of NXT USA, said achieving the patent is a watershed moment in a category — joint health — that has seen a low level of innovation and research in recent years. And what research has been done has often been on diseased populations, with dubious applicability to consumers with only mild or occasional joint discomfort.
TamaFlex, on the other hand, has good data showing its effects in health subjects, helping weekend warriors tackle strenuous activity with less fear of being debilitated with joint afterward.
“TamaFlex is clinically validated in both healthy participants and participants with mild joint discomfort to provide benefits in just five days. In comparison, most joint products rely on data from folks with existing health conditions and need extended periods of time to provide efficacy,” Anderson said.
Recognition of novelty of concept
Anderson said the patent recognizes the ground breaking work the scientists who developed the ingredient have done.
“In order to be awarded a patent, the discovery needs to be novel and non-obvious. Thus the research who made this discovery and demonstrated the efficacy have heled create an entirely new ingredient for joint health with significant benefits for joint health, and healthy inflammation response systemically,” he said.
Anderson said the hope is that the patent will help protect the field from me-too imitators. At the ned of the day NXT USA stands ready to legally defend the patent if it came to that, he said.
“We also feel that it is important for the finished product companies that incorporate our ingredient to know that there is some protection against those that steal science and often bring inferior imitations to market,” Anderson added.